# A Study of SRSD384 in Overweight or Obese Participants

> **NCT07557355** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Sirius Therapeutics Co., Ltd.** · enrollment: 78 (estimated)

## Conditions studied

- Overweight , Obesity

## Interventions

- **DRUG:** SRSD384 injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07557355
- **Lead sponsor:** Sirius Therapeutics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07557355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07557355, "A Study of SRSD384 in Overweight or Obese Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07557355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*